RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Musiliyu Musa to Breast Neoplasms

This is a "connection" page, showing publications Musiliyu Musa has written about Breast Neoplasms.
Connection Strength

0.553
  1. Musa MA, Badisa VLD, Latinwo LM, Ntantie E. 7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells. Anticancer Res. 2018 Nov; 38(11):6091-6098.
    View in: PubMed
    Score: 0.299
  2. Musa MA, Cooperwood JS, Khan MO. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem. 2008; 15(26):2664-79.
    View in: PubMed
    Score: 0.141
  3. Wan Z, Musa MA, Joseph P, Cooperwood JS. Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents. Mini Rev Med Chem. 2013 Jul; 13(9):1381-8.
    View in: PubMed
    Score: 0.052
  4. Musa MA, Khan MO, Cooperwood JS. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs). Curr Med Chem. 2007; 14(11):1249-61.
    View in: PubMed
    Score: 0.033
  5. Aghimien MO, Kolawole Q, Igbinoba PO, Musa MA, Latinwo L. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes. Anticancer Res. 2024 Jun; 44(6):2335-2341.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support